Accendra Health (ACH) Shares Outstanding (Weighted Average) (2009 - 2026)

Accendra Health (ACH) has 18 years of Shares Outstanding (Weighted Average) data on file, last reported at $76.4 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $76.4 million, down 1.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $76.4 million (down 1.09% YoY), and the FY2025 annual result was $76.9 million, changed 0.2% from the prior year.
• Shares Outstanding (Weighted Average) eased to $76.4 million in Q1 2026 per ACH's latest filing, from $76.9 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $77.3 million in Q3 2025 and troughed at $73.6 million in Q1 2022.
• A 5-year average of $75.9 million and a median of $76.3 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Weighted Average) advanced 3.97% in 2022, then dropped 1.09% in 2026.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $74.5 million in 2022, then gained by 1.73% to $75.8 million in 2023, then climbed by 1.26% to $76.7 million in 2024, then climbed by 0.2% to $76.9 million in 2025, then slipped by 0.6% to $76.4 million in 2026.
• Business Quant data shows ACH's Shares Outstanding (Weighted Average) at $76.4 million in Q1 2026, $76.9 million in Q4 2025, and $77.3 million in Q3 2025.